Nuclear radiopharmaceuticals medicine
Ended Awarded Last action
- Contract number
- 36C26124N0005
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI EQ4VSLH8RC33
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $71,448
Award facts
- Contract value 100% obligated
- $71,447.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$73,707 | |
| Original award | $145,155 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a $71,447.90 firm fixed price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on October 1, 2023, for the supply of nuclear radiopharmaceuticals and medical imaging agents. The contract, which was not set aside, is scheduled for completion by September 30, 2024, with performance occurring in San Francisco, California. Jubilant Radiopharma, a self-certified small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, specializes in manufacturing and distributing specialized radiopharmaceutical products including medical isotopes such as Gallium 68 Dotatate, iodine I-123, and technetium-99m used in diagnostic imaging, PET scans, and cancer treatment applications.
This delivery order is part of the broader relationship between Jubilant Radiopharma and the VA, which has awarded the company multiple Indefinite Delivery Vehicles and blanket purchase agreements across various VISNs nationwide. The company holds several significant IDVs with potential values ranging from $420,000 to $39.8 million, enabling efficient procurement of critical nuclear medicine products to support healthcare services for veterans across the VA's regional networks. The award reflects Jubilant Radiopharma's established capability to supply essential radiopharmaceutical products to federal healthcare agencies, supporting diagnostic procedures and treatment initiatives throughout the VA system.
Quick answers
Who was awarded contract 36C26124N0005?
36C26124N0005 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C26124N0005 worth?
The government has obligated $71,448 on 36C26124N0005.
Is contract 36C26124N0005 an order under another contract?
Yes. 36C26124N0005 is a delivery order under 36C26122D0063, an indefinite delivery contract.
Was contract 36C26124N0005 competed?
The extent of competition for 36C26124N0005 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award